Liraglutide achieves HbA1c targets more often than sitagliptin or exenatide when added to metformin in patients with Type 2 diabetes and a baseline HbA1c < 8.0% Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Davies, M., King, A. B., Montanya, E., Pratley, R. E., Blonde, L., Svendsen, C. B., Donsmark, M., Sesti, G.

authors

Publication Date

  • March 1, 2013

webpage

published in

category

start page

  • 57

end page

  • 57

volume

  • 30

WoS Citations

  • 0

WoS References

  • 0